Lukasz J. Ochyl

3.3k total citations · 2 hit papers
21 papers, 2.8k citations indexed

About

Lukasz J. Ochyl is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Lukasz J. Ochyl has authored 21 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Lukasz J. Ochyl's work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Response and Inflammation (4 papers). Lukasz J. Ochyl is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Response and Inflammation (4 papers). Lukasz J. Ochyl collaborates with scholars based in United States, South Korea and Germany. Lukasz J. Ochyl's co-authors include James J. Moon, Rui Kuai, Anna Schwendeman, Keith S. Bahjat, Sejin Son, Jutaek Nam, Yao Xu, Yuchen Fan, Darrell J. Irvine and James J. Moon and has published in prestigious journals such as Nature Communications, Nature Materials and Nano Letters.

In The Last Decade

Lukasz J. Ochyl

21 papers receiving 2.8k citations

Hit Papers

Designer vaccine nanodiscs for personalized cancer immuno... 2016 2026 2019 2022 2016 2018 250 500 750

Peers

Lukasz J. Ochyl
Shaomin Tian United States
Conlin P. O’Neil Switzerland
Jiarong Zhou United States
Lei Miao United States
Eiji Yuba Japan
Ashley V. Kroll United States
Shaomin Tian United States
Lukasz J. Ochyl
Citations per year, relative to Lukasz J. Ochyl Lukasz J. Ochyl (= 1×) peers Shaomin Tian

Countries citing papers authored by Lukasz J. Ochyl

Since Specialization
Citations

This map shows the geographic impact of Lukasz J. Ochyl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukasz J. Ochyl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukasz J. Ochyl more than expected).

Fields of papers citing papers by Lukasz J. Ochyl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukasz J. Ochyl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukasz J. Ochyl. The network helps show where Lukasz J. Ochyl may publish in the future.

Co-authorship network of co-authors of Lukasz J. Ochyl

This figure shows the co-authorship network connecting the top 25 collaborators of Lukasz J. Ochyl. A scholar is included among the top collaborators of Lukasz J. Ochyl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukasz J. Ochyl. Lukasz J. Ochyl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernett, Matthew J., Suzanne Schubbert, Michael Hackett, et al.. (2022). Abstract 2080: LAG3-targeted IL15/IL15Rα-Fc (LAG3 x IL15) fusion proteins for preferential TIL expansion. Cancer Research. 82(12_Supplement). 2080–2080. 4 indexed citations
2.
Son, Sejin, Jutaek Nam, Lukasz J. Ochyl, et al.. (2020). Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination. Nano Letters. 20(3). 1499–1509. 80 indexed citations
3.
Park, Kyong Soo, Joseph Bazzill, Sejin Son, et al.. (2020). Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2. Journal of Controlled Release. 330. 529–539. 38 indexed citations
4.
Habibi, Nahal, Stephanie Christau, Lukasz J. Ochyl, et al.. (2020). Engineered Ovalbumin Nanoparticles for Cancer Immunotherapy. Advanced Therapeutics. 3(10). 34 indexed citations
5.
Louttit, Cameron, Taisuke Kojima, Srilakshmi Yalavarthi, et al.. (2019). Extracellular Trap‐Mimicking DNA‐Histone Mesostructures Synergistically Activate Dendritic Cells. Advanced Healthcare Materials. 8(22). e1900926–e1900926. 8 indexed citations
6.
Ochyl, Lukasz J., et al.. (2018). PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy. Biomaterials. 182. 157–166. 96 indexed citations
7.
Bazzill, Joseph, Lukasz J. Ochyl, Jesse Steffens, et al.. (2018). Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses. Nanomedicine Nanotechnology Biology and Medicine. 18. 414–425. 20 indexed citations
8.
Nam, Jutaek, Sejin Son, Lukasz J. Ochyl, et al.. (2018). Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer. Nature Communications. 9(1). 1074–1074. 691 indexed citations breakdown →
9.
Kuai, Rui, Xiaoqi Sun, Wenmin Yuan, et al.. (2018). Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy. Journal of Controlled Release. 282. 131–139. 110 indexed citations
10.
Ochyl, Lukasz J. & James J. Moon. (2018). Dendritic Cell Membrane Vesicles for Activation and Maintenance of Antigen‐Specific T Cells. Advanced Healthcare Materials. 8(4). e1801091–e1801091. 44 indexed citations
11.
12.
Ochyl, Lukasz J., et al.. (2018). Self‐healing encapsulation and controlled release of vaccine antigens from PLGA microparticles delivered by microneedle patches. Bioengineering & Translational Medicine. 4(1). 116–128. 54 indexed citations
13.
Desai, Kashappa Goud H., et al.. (2017). Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery. Molecular Pharmaceutics. 14(9). 3228–3237. 33 indexed citations
14.
Gao, Jie, Lukasz J. Ochyl, Ellen Yang, & James J. Moon. (2017). Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens. International Journal of Nanomedicine. Volume 12. 1251–1264. 73 indexed citations
15.
Fan, Yuchen, Rui Kuai, Yao Xu, et al.. (2017). Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy. Nano Letters. 17(12). 7387–7393. 193 indexed citations
16.
Kuai, Rui, Lukasz J. Ochyl, Keith S. Bahjat, Anna Schwendeman, & James J. Moon. (2016). Designer vaccine nanodiscs for personalized cancer immunotherapy. Nature Materials. 16(4). 489–496. 879 indexed citations breakdown →
17.
Fan, Yuchen, et al.. (2015). Cationic liposome–hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens. Journal of Controlled Release. 208. 121–129. 135 indexed citations
18.
Ochyl, Lukasz J. & James J. Moon. (2015). Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination. Journal of Visualized Experiments. e52771–e52771. 11 indexed citations
19.
Ochyl, Lukasz J. & James J. Moon. (2015). Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination. Journal of Visualized Experiments. 3 indexed citations
20.
Ochyl, Lukasz J., et al.. (2014). Biomaterials for Nanoparticle Vaccine Delivery Systems. Pharmaceutical Research. 31(10). 2563–2582. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026